Shire (SHPGY) Q1 2012 Earnings Call April 26, 2012 9:00 am ET Executives Eric Rojas - Director of Investor Relations - North America Angus C. Russell - Chief Executive Officer and Executive Director Sylvie Gregoire - President of Human Genetic Therapies Business and Member of Management Committee Graham Hetherington - Chief Financial Officer, Principal Accounting Officer and Director Jeff Jonas - Senior Vice President of Research & Development for Pharmaceuticals Business Analysts Gary Nachman - Susquehanna Financial Group, LLLP, Research Division Brian White - Shore Capital Group Ltd., Research Division David M. Steinberg - Deutsche Bank AG, Research Division Graham Parry - BofA Merrill Lynch, Research Division David Amsellem - Piper Jaffray Companies, Research Division Keyur Parekh - Goldman Sachs Group Inc., Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Shire's 2012 First Quarter Results Call hosted by Eric Rojas. My name is Jo, and I'm your event manager today. [Operator Instructions] I would like to advise all parties that this conference is being recorded for replay purposes. And I would like to hand the call over to your host, Eric. Please go ahead. Eric Rojas Thanks, Jo. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's First Quarter 2012 Financial Results. By now, you should have all received our press release and should be viewing our presentation via our website on shire.com. If for some reason you have not received the press release or are unable to access our website, please contact Souheil Salah in our U.K. Investor Relations department at +44-1256-894-160, and he will be happy to assist you.